Artisan合夥資產管理 APAM 深 滬
等待開盤 05-13 09:30:00 美东时间
36.94
-0.670
-1.78%
華盛通- 最 高37.53
- 今 開37.53
- 成交量 77.85万股
- 最 低 36.56
- 昨 收 37.61
- 總市值 29.94亿
- 52周最高 45.31
- 市盈率 靜 9.11
- 換手率 0.96%
- 52周最低 34.99
- 委 比 99.00%
- 總股本 8105.78万
- 歷史最高 45.31
- 量 比 1.36
- 振 幅 2.58%
- 歷史最低 -9.81
- 每 手 1
- 風險率 2.48%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Artisan Partners Reports April 2026 Assets Under Management
Artisan Partners ( ($APAM) ) has shared an announcement. Artisan Partners Asset...
05-12 05:38
美股大行评级 | 潜在涨幅128.69%！Immunic获HC Wainwright & Co.升目标价至22美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Immunic"买入"评级，目标价从5美元升至22美元；花旗：维持ServiceNow"买入"评级，目标价从154美元升至158美元
05-01 10:49
Evercore ISI Group Maintains In-Line on Artisan Partners Asset, Raises Price Target to $38
Evercore ISI Group analyst John Dunn maintains Artisan Partners Asset (NYSE:APAM) with a In-Line and raises the price target from $37 to $38.
04-30 22:52
Full Transcript: Artisan Partners Asset Q1 2026 Earnings Call
Artisan Partners Asset (NYSE:APAM) released first-quarter financial results and...
04-29 23:46
Artisan Partners Asset Management declares $0.77 dividend
Artisan Partners Asset Management (APAM) declares $0.77/share quarterly dividend. Payable May 29; for shareholders of record May 15; ex-div May 15. See APAM Dividend Scorecard, Yield Chart, & Dividend...
04-29 21:41
财报速睇 | Artisan合伙资产管理 2026财年Q1营收3.03亿美元，同比增长9.4%；归母净利润0.58亿美元，同比下滑4.9%
华盛资讯4月29日讯，Artisan合伙资产管理公布2026财年Q1业绩，公司Q1营收3.03亿美元，同比增长9.4%，归母净利润0.58亿美元，同比下滑4.9%。
04-29 06:44
Artisan Partners Asset Q1 Adj. EPS $0.87 Misses $0.94 Estimate, Sales $303.000M Miss $303.462M Estimate.
Artisan Partners Asset (NYSE:APAM) reported quarterly earnings of $0.87 per share which missed the analyst consensus estimate of $0.94 by 7.45 percent. This is a 4.82 percent increase over earnings of $0.83 per share
04-29 04:28
Earnings Scheduled For April 28, 2026
Companies Reporting Before The Bell • LGI Homes (NASDAQ:LGIH) is likely to repo...
04-28 19:11
美股大行评级 | 大砍54%！大摩下调Robinhood 目标价从147降至95美元；星座品牌酒业(STZ)获8家大行上调目标价
今日重点评级关注：Ascendiant Capital：维持Allarity Therapeutics"买入"评级，目标价从9.5美元升至9.75美元；Citizens：维持戴夫"跑赢大市"评级，目标价从310美元升至335美元
04-13 14:07
